Technical / White Paper
The World is Changing, Talk to Marken
The landscape of the clinical trial supply chain is changing throughout the world. Patient centricities and immune, cell and gene therapies are now the foundation of most treatments methods. The new EU regulations and Good Distribution Practices (GDP) guidelines, along with the industry’s need to decrease cost, reduce time to market and a harmonization of rules call for radical changes in the way trials are conducted.
